HighTide Therapeutics
Pharmaceutical ManufacturingView the employees at
HighTide Therapeutics-
Alex Liberman Clinical Scientist
-
San Diego County, California, United States
-
Rising Star
Kjersti (Hoyer) Swearingen Associate Director, Medical Writing-
Greater Seattle Area
-
Rising Star
Edmund Sim CFO at HighTide Therapeutics-
Hong Kong, Hong Kong SAR
-
Rising Star
Leigh MacConell Chief Development Officer at HighTide Therapeutics-
Encinitas, California, United States
-
Rising Star
Cathryn Bennett VP, Clinical Operations, HighTideTherapeutics USA-
Carlsbad, California, United States
-
Top 10%
Overview
HighTide Therapeutics, Inc. is a globally integrated biopharmaceutical company focusing on the discovery and development of first-in-class multifunctional therapies with poly-indications across metabolic and digestive diseases with significant unmet medical needs. The company is developing multiple clinical assets, including therapy for nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC). HTD1801, the company’s lead drug candidate, received Fast Track designation from the U.S. for both NASH and PSC, as well as Orphan Drug designation for PSC. In China, HTD1801 has been included in the National Major New Drug Innovation Program under the 13th Five-Year Plan for Major Technology Project.
-